Literature DB >> 28475895

SLERT Regulates DDX21 Rings Associated with Pol I Transcription.

Yu-Hang Xing1, Run-Wen Yao1, Yang Zhang1, Chun-Jie Guo1, Shan Jiang1, Guang Xu1, Rui Dong2, Li Yang3, Ling-Ling Chen4.   

Abstract

Dysregulated rRNA synthesis by RNA polymerase I (Pol I) is associated with uncontrolled cell proliferation. Here, we report a box H/ACA small nucleolar RNA (snoRNA)-ended long noncoding RNA (lncRNA) that enhances pre-rRNA transcription (SLERT). SLERT requires box H/ACA snoRNAs at both ends for its biogenesis and translocation to the nucleolus. Deletion of SLERT impairs pre-rRNA transcription and rRNA production, leading to decreased tumorigenesis. Mechanistically, SLERT interacts with DEAD-box RNA helicase DDX21 via a 143-nt non-snoRNA sequence. Super-resolution images reveal that DDX21 forms ring-shaped structures surrounding multiple Pol I complexes and suppresses pre-rRNA transcription. Binding by SLERT allosterically alters individual DDX21 molecules, loosens the DDX21 ring, and evicts DDX21 suppression on Pol I transcription. Together, our results reveal an important control of ribosome biogenesis by SLERT lncRNA and its regulatory role in DDX21 ring-shaped arrangements acting on Pol I complexes.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DDX21; RNA polymerase I; SIM; SLERT; nucleolus; sno-lncRNA

Mesh:

Substances:

Year:  2017        PMID: 28475895     DOI: 10.1016/j.cell.2017.04.011

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  75 in total

1.  Dissecting the Role of DDX21 in Regulating Human Cytomegalovirus Replication.

Authors:  Hongyun Hao; Tian Han; Baoqin Xuan; Yamei Sun; Shubing Tang; Nan Yue; Zhikang Qian
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

Review 2.  Long Noncoding RNA Discovery in Cardiovascular Disease: Decoding Form to Function.

Authors:  Tamer Sallam; Jaspreet Sandhu; Peter Tontonoz
Journal:  Circ Res       Date:  2018-01-05       Impact factor: 17.367

Review 3.  Illuminating Genomic Dark Matter with RNA Imaging.

Authors:  Arjun Raj; John L Rinn
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-05-01       Impact factor: 10.005

4.  Mechanism of long noncoding RNAs as transcriptional regulators in cancer.

Authors:  Yan Huang; Qi Guo; Xi-Ping Ding; Xiangting Wang
Journal:  RNA Biol       Date:  2020-01-10       Impact factor: 4.652

5.  An LTR retrotransposon-derived lncRNA interacts with RNF169 to promote homologous recombination.

Authors:  Bing Deng; Wenli Xu; Zelin Wang; Chang Liu; Penghui Lin; Bin Li; Qiaojuan Huang; Jianhua Yang; Hui Zhou; Lianghu Qu
Journal:  EMBO Rep       Date:  2019-09-05       Impact factor: 8.807

6.  LncRNA HAND2-AS1 promotes liver cancer stem cell self-renewal via BMP signaling.

Authors:  Yanying Wang; Pingping Zhu; Jianjun Luo; Jing Wang; Zhiwei Liu; Wei Wu; Ying Du; Buqing Ye; Dongpeng Wang; Lei He; Weizheng Ren; Jianyi Wang; Xianhui Sun; Runsheng Chen; Yong Tian; Zusen Fan
Journal:  EMBO J       Date:  2019-07-23       Impact factor: 11.598

Review 7.  Nuclear Long Noncoding RNAs: Key Regulators of Gene Expression.

Authors:  Qinyu Sun; Qinyu Hao; Kannanganattu V Prasanth
Journal:  Trends Genet       Date:  2018-02-07       Impact factor: 11.639

8.  circMYBL2, a circRNA from MYBL2, regulates FLT3 translation by recruiting PTBP1 to promote FLT3-ITD AML progression.

Authors:  Yu-Meng Sun; Wen-Tao Wang; Zhan-Cheng Zeng; Tian-Qi Chen; Cai Han; Qi Pan; Wei Huang; Ke Fang; Lin-Yu Sun; Yan-Fei Zhou; Xue-Qun Luo; Chengwei Luo; Xin Du; Yue-Qin Chen
Journal:  Blood       Date:  2019-10-31       Impact factor: 22.113

Review 9.  Hiding in Plain Sight: Rediscovering the Importance of Noncoding RNA in Human Malignancy.

Authors:  Kyle P Feeley; Mick D Edmonds
Journal:  Cancer Res       Date:  2018-04-09       Impact factor: 12.701

Review 10.  Cellular functions of long noncoding RNAs.

Authors:  Run-Wen Yao; Yang Wang; Ling-Ling Chen
Journal:  Nat Cell Biol       Date:  2019-05-02       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.